Edesa Biotech, Inc. 是一家临床阶段的生物制药公司,致力于炎症和免疫相关疾病的药物研发、生产与营销。公司总部位于加拿大万锦市。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$5.09万
2025-12-31
$0
2025-09-30
$0
营业支出
2026-06-30
$551.95万
2026-03-31
$427.11万
2025-12-31
$231.59万
2025-09-30
$244.43万
净利润
2026-06-30
-$540.76万
2026-03-31
-$421.83万
2025-12-31
-$224.76万
2025-09-30
-$222.83万
净利润率
2026-06-30
--
2026-03-31
-8.28K%
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-0.60
2026-03-31
$-0.49
2025-12-31
$-0.28
2025-09-30
$-0.32
息税折旧摊销前利润
2026-06-30
-$549.39万
2026-03-31
-$427.11万
2025-12-31
-$231.59万
2025-09-30
-$219.72万
有效税率
2026-06-30
--
2026-03-31
-0.01%
2025-12-31
--
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$5.09万
$0
$0
营业支出
$551.95万
$427.11万
$231.59万
$244.43万
净利润
-$540.76万
-$421.83万
-$224.76万
-$222.83万
净利润率
--
-8.28K%
--
--
每股收益
$-0.60
$-0.49
$-0.28
$-0.32
息税折旧摊销前利润
-$549.39万
-$427.11万
-$231.59万
-$219.72万
有效税率
--
-0.01%
--
--
常见问题
EDSA represents shares of a publicly traded company listed on a U.S. stock exchange under the ticker EDSA. It gives investors exposure to the underlying business's operations and financial performance. Like other equities, EDSA trades during normal market hours and its price fluctuates based on supply and demand. For the latest company description and listing details, check the EDSA stock page.
Recent performance for EDSA depends on current market conditions and company developments, so specific price moves should be checked on the stock page. You can review the latest quote, daily change, and percentage move there. Longer-term context, such as monthly or yearly returns, is also typically shown alongside the current price to help frame recent activity.
Valuation for EDSA involves comparing its market price against financial fundamentals. Common tools include price-to-earnings, price-to-sales, and price-to-book ratios, along with enterprise value multiples. These metrics are most useful when compared with industry peers and the company's own historical range. The EDSA stock page displays relevant valuation data so you can assess whether the shares appear cheap or expensive relative to those benchmarks.
EDSA can typically be bought or sold through a brokerage account that offers access to U.S. stock exchanges. Orders may be placed during regular trading hours, and some brokers also support extended-hours trading. Availability of EDSA for trading depends on your broker and your account type. Check with your brokerage for specifics on order types, fees, and any restrictions that may apply.
Analyzing EDSA's financial performance starts with its quarterly and annual reports. Key items include revenue growth, gross and operating margins, net income, and cash flow from operations. Comparing these figures over several periods helps reveal trends in profitability and efficiency. Balance sheet metrics, such as debt levels and liquidity, also provide context. EDSA's financial statements are available through its investor relations filings and the stock page.
EDSA shares carry risks tied to the company's business, its industry, and broader market conditions. These may include competitive pressures, regulatory changes, operational challenges, and sensitivity to economic cycles. Stock-specific risks can also involve customer concentration, execution on growth plans, or financing needs. Market-wide factors such as interest rates and investor sentiment can affect the share price as well. Reviewing EDSA's risk disclosures in its regulatory filings provides a fuller picture.